Please use this identifier to cite or link to this item:
Title: Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia.
Austin Authors: Kutaiba, Numan ;Gow, Paul J ;French, Janine ;Lim, Ruth P 
Affiliation: Radiology, Austin Health Melbourne, Victoria, Australia
Liver Transplant Unit, Austin Hospital Melbourne, Victoria, Australia
Issue Date: 17-Nov-2014
Publication information: Clinical Case Reports 2014; 3(1): 32-3
Abstract: Our case report demonstrates the use of phase contrast magnetic resonance imaging (MRI) in monitoring the functional status of liver vasculature in a patient with hereditary hemorrhagic telangiectasia (HHT) who was treated with bevacizumab. Our report provides additional information that can be further utilized in clinical settings and research.
Gov't Doc #: 25678970
DOI: 10.1002/ccr3.141
Type: Journal Article
Subjects: Angiogenesis inhibitors
blood flow velocity
hepatic artery
hereditary hemorrhagic telangiectasia
magnetic resonance imaging
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 9, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.